Skip to main content
BMC Infectious Diseases logoLink to BMC Infectious Diseases
. 2017 Jun 23;17:446. doi: 10.1186/s12879-017-2545-z

Erratum to: Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in mid-Norway: a prospective observational study

Arne Mehl 1,2,3,✉, Bjørn Olav Åsvold 3,4,5, Angela Kümmel 6, Stian Lydersen 7, Julie Paulsen 1,3,8, Ingvild Haugan 9, Erik Solligård 3,10,11, Jan Kristian Damås 3,8,12, Stig Harthug 13,14, Tom-Harald Edna 2,15
PMCID: PMC5481901  PMID: 28645322

Erratum

After publication of the original article [1] the authors found the following errors had occurred:

  1. The y-axis of Fig. 3 has been incorrectly titled ‘Percent’. The correct title is ‘Number of episodes’. (Fig. 3).

  • 2.

    The legend of Fig. 3 did not contain correct information on the figure.

Fig. 3.

Fig. 3

Number of BSI episodes with microbe(s) non-susceptible to penicillin-gentamicin-metronidazole (PGM) through three time periods. Additional file 1: Table S5 shows the PGM non-susceptible microbes in detail. The percentages of episodes with microbe(s) non-susceptible to PGM were 1.9%, 3.0%, and 5.2% in 2002–2005, 2006–2009, and 2010–2013, respectively. ANS, acquired non-susceptibility; INS, inherent non-susceptibility

The legend on Fig. 3 was originally labelled:

Microbes non-susceptible to penicillin-gentamicin-metronidazole (PGM) through three time periods. (Additional file 1: Table S5 shows the PGM non-susceptible microbes in detail) ANS, acquired non-susceptibility; INS, inherent non-susceptibility

However, this has been corrected to:

Number of BSI episodes with microbe(s) non-susceptible to penicillin-gentamicin-metronidazole (PGM) through three time periods. Additional file 1: Table S5 shows the PGM non-susceptible microbes in detail. The percentages of episodes with microbe(s) non-susceptible to PGM were 1.9%, 3.0%, and 5.2% in 2002–2005, 2006–2009, and 2010–2013, respectively. ANS, acquired non-susceptibility; INS, inherent non-susceptibility (Fig. 3)

A corrected version of the figure is included in this Erratum:

Footnotes

The online version of the original article can be found under doi:10.1186/s12879-017-2210-6

Reference

  • 1.Mehl A, Åsvold BO, Kümmel A, Lydersen S, Paulsen J, Haugan I, Solligård E, Damås JK, Harthug S, Edna T-H. BMC Infectious Diseases. 2017;17:116. doi: 10.1186/s12879-017-2210-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Infectious Diseases are provided here courtesy of BMC

RESOURCES